SBIR-STTR Award

Rnai Cancer Therapeutics Using Nanotechnology. Phase I. Hhsn26120
Award last edited on: 1/2/19

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$200,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Troy Wilson

Company Information

Avidity Biosciences Inc (AKA: Avidity Nanomedicines LLC)

10578 Science Center Drive Suite 125
San Diego, CA 92121
   (858) 401-7900
   email@aviditybiosciences.com
   www.aviditybiosciences.com
Location: Single
Congr. District: 50
County: San Diego

Phase I

Contract Number: 261201300031C-0-0-1
Start Date: 9/20/13    Completed: 6/19/14
Phase I year
2013
Phase I Amount
$200,000
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.

Project Terms:
base; cancer therapy; design; Drug Formulations; Malignant Neoplasms; nanoparticle; Nanotechnology; novel; Phase; preclinical evaluation; RNA Interference; Small Business Innovation Research Grant; Therapeutic; Therapeutic Uses

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----